Cargando…

Clinical aspects and risk factors of lupus nephritis: a retrospective study of 156 adult patients

OBJECTIVE: To analyze the clinical manifestations, laboratory indexes, disease activity, and pathological types of lupus nephritis (LN) in adult patients. METHODS: We retrospectively analyzed the clinical manifestations, laboratory indexes, and pathological classifications of 156 adult patients firs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Fang, Wei, Fenghua, Wang, Junjie, You, Yanwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Clinical Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833424/ https://www.ncbi.nlm.nih.gov/pubmed/31510838 http://dx.doi.org/10.1177/0300060519871812

Ejemplares similares

FKN Facilitates HK-2 Cell EMT and Tubulointerstitial Lesions via the Wnt/β-Catenin Pathway in a Murine Model of Lupus Nephritis
por: Fu, Dongdong, et al.
Publicado: (2019)

Two faces of lupus nephritis? Questions
por: Doğantan, Şeyda, et al.
Publicado: (2021)

Clinical and Genetic Risk Factors Associated With the Presence of Lupus Nephritis
por: Shin, Jung-Min, et al.
Publicado: (2021)

Lupus Nephritis Risk Factors and Biomarkers: An Update
por: Renaudineau, Yves, et al.
Publicado: (2023)

Lupus Nephritis in Males: Clinical Features, Course, and Prognostic Factors for End-Stage Renal Disease
por: Urrestarazú, Andrés, et al.
Publicado: (2017)

Lupus nephritis in children – 10 years’ experience
por: Szymanik-Grzelak, Hanna, et al.
Publicado: (2016)

Effect of Thrombotic Microangiopathy on Clinical Outcomes in Indian Patients With Lupus Nephritis
por: Pattanashetti, N., et al.
Publicado: (2017)

Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients
por: Liu, Xin-ran, et al.
Publicado: (2023)

Hydralazine-Induced Isolated Lupus Nephritis
por: Khan, Naseer, et al.
Publicado: (2020)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Circulating Angiogenic T Cells Are Increased in Lupus Nephritis Patients
por: Zhao, Peng, et al.
Publicado: (2018)

De novo lupus nephritis during treatment with belimumab
por: Parodis, Ioannis, et al.
Publicado: (2020)

Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention
por: Banos, Aggelos, et al.
Publicado: (2023)

Lupus nephritis or not? A simple and clinically friendly machine learning pipeline to help diagnosis of lupus nephritis
por: Wang, Da-Cheng, et al.
Publicado: (2023)

Risk factors for subsequent lupus nephritis in patients with juvenile-onset systemic lupus erythematosus: a retrospective cohort study
por: Hsu, Tzu-Chuan, et al.
Publicado: (2023)

Rescue treatment of severe lupus myocarditis and proliferative lupus nephritis with immunoadsorption
por: Štambuk, Sandra Karanović, et al.
Publicado: (2023)

Biomarker Profiling for Lupus Nephritis
por: Li, Yajuan, et al.
Publicado: (2013)

Urine and serum interleukin 35 as potential biomarkers of lupus nephritis
por: Nassif, Mary Atef
Publicado: (2021)

Stronger Correlation between Interleukin 18 and Soluble Fas in Lupus Nephritis Compared with Mild Lupus
por: Hatef, Mohammad Reza, et al.
Publicado: (2013)

The Outcome of Patients with Lupus Nephritis and the Impact of Cardiovascular Risk Factors
por: Drakoulogkona, O., et al.
Publicado: (2011)

HOXA11-OS participates in lupus nephritis by targeting miR-124-3p mediating Cyr61 to regulate podocyte autophagy
por: Pan, Xiuhong, et al.
Publicado: (2022)

East-Asian lupus nephritis in the Hopkins Lupus Cohort
por: Petri, Michelle, et al.
Publicado: (2023)

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
por: Isenberg, David, et al.
Publicado: (2010)

Systematic Review and the External Validity of Randomized Controlled Trials in Lupus Nephritis
por: Pakozdi, Angela, et al.
Publicado: (2017)

Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody
por: Wang, Shuai, et al.
Publicado: (2020)

A Systematic Review of Interpathologist Agreement in Histologic Classification of Lupus Nephritis
por: Dasari, Shobha, et al.
Publicado: (2019)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
por: Houssiau, Frédéric A, et al.
Publicado: (2010)

Renal deposits of complement factors as predictors of end-stage renal disease and death in patients with lupus nephritis
por: Koopman, Jacob J E, et al.
Publicado: (2020)

Association of Intrarenal B-Cell Infiltrates with Clinical Outcome in Lupus Nephritis: A Study of 192 Cases
por: Shen, Yan, et al.
Publicado: (2012)

Differing environmental risk factors for membranous versus proliferative lupus nephritis
por: Dooley, MA, et al.
Publicado: (2012)

Geographical distribution, a risk factor for the incidence of lupus nephritis in China
por: Pan, Qingjun, et al.
Publicado: (2014)

Lupus nephritis pathology prediction with clinical indices
por: Tang, Youzhou, et al.
Publicado: (2018)

Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019)

Regulation of MiR-146a and TRAF6 in the Diagnose of Lupus Nephritis
por: Zhu, Yunfeng, et al.
Publicado: (2017)

Association of Lupus Nephritis Histopathologic Classification With Venous Thromboembolism—Modification by Age at Biopsy
por: Cooley, Ian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_665aek3d2c2ba8hger93m1ugt2